A

Aegis Ventures

Launches AI-driven health tech companies

Compliance Lead

Full-TimeUpdated on 10/3/2026
$160k - $180k+ Equity
Senior
Remote in USA+2 moreMore locations: Irvine, CA, USA | Columbus, OH, USA
Remote

About the job

Requirements
  • At least 5 years of hands-on compliance experience at a B2B SaaS or healthcare technology company.
  • Demonstrated ownership of HIPAA compliance programs and working knowledge of HITRUST i1 or r2.
  • Experience with SOC 2 Type II, including coordinating evidence, managing auditors, and closing gaps.
  • Ability to work cross-functionally with Engineering on technical controls.
  • Strong written communication for policy writing, questionnaire responses, and executive summaries.
  • Ability to build structure in ambiguous situations.
Responsibilities
  • Own Avandra's compliance roadmap across HIPAA, HITRUST, and SOC 2, and drive certification timelines and recertification cycles.
  • Maintain the risk register and conduct company-wide risk assessments on a defined cadence.
  • Author, publish, and maintain security and compliance policies and procedures.
  • Evaluate emerging frameworks, including ISO 27001 and NIST CSF, for relevance as the company scales.
  • Coordinate evidence collection, gap assessments, and control testing across Engineering, Operations, and People teams.
  • Manage relationships with external assessors and compliance-automation platforms.
  • Maintain audit-ready documentation at all times.
  • Own the vendor security intake and assessment process.
  • Respond to customer security questionnaires, RFPs, and due diligence requests, and represent Avandra's compliance posture to health system partners.
  • Conduct compliance assessments for acquisition targets, evaluating PHI handling practices, existing certifications, policy maturity, and open audit findings.
  • Own the post-acquisition compliance integration playbook, including gap analysis, remediation roadmap, and timeline to bring acquired entities under Avandra's compliance umbrella.
  • Assess and rationalize subsidiary compliance programs, identifying redundancies, coverage gaps, and certification consolidation opportunities.
  • Contribute to cross-functional M&A workstreams alongside Legal, Finance, and Engineering as the compliance integration contributor.
  • Maintain a consolidated compliance posture across all entities, ensuring subsidiaries operate within Avandra's policy and control framework.
  • Develop and deliver company-wide compliance training, including onboarding programs tailored to acquired teams.
  • Translate complex regulatory requirements into clear, actionable guidance for non-compliance teams.
Desired Qualifications
  • Experience supporting compliance assessments or integration work in M&A contexts.
  • Familiarity with multi-entity or subsidiary compliance program management.
  • CISSP, CISM, HCISPP, or equivalent certification.
  • Experience with compliance automation tools such as Vanta, Drata, or Tugboat Logic.
  • Familiarity with PHI data flows, health data integrations, and healthcare data contracts.
  • Prior experience at a growth-stage startup where the compliance program was being created rather than inherited.

About the company

Aegis Ventures is a startup studio that partners with entrepreneurs and industry leaders to originate, launch, and scale new companies focused on AI and health tech. It operates a platform that combines market-shaping ideas, permanent growth capital, and ambitious people to identify opportunities, fund them long-term, and provide hands-on operational support. Unlike traditional funds, it creates companies in-house with a built-in path to rapid growth, with a strong emphasis on transforming healthcare quality, access, and cost. Its goal is to build companies capable of vast impact by using technology to improve health outcomes and societal wellbeing.

Company Size

11-50

Company Stage

N/A

Total Funding

$33.1M

Headquarters

New York City, New York

Founded

2020

Get referred to Aegis Ventures

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Wavelet secured $7 million on April 14, 2026, and is piloting at Yale and USC.
  • Optain acquired EyePACS in November 2025 and now serves 200 provider sites globally.
  • Aegis added Bunny Ellerin on April 6, 2026 and published a medtech AI whitepaper.

What critics are saying

  • Wavelet’s fetal EEG needs regulatory clearance and obstetric adoption before proving commercial demand.
  • Optain’s teleophthalmology rollout depends on reimbursement, workflow integration, and specialist validation.
  • Aegis’ public sites conflict on healthtech versus blockchain messaging, confusing talent and investors.

What makes Aegis Ventures unique

  • Aegis launched six healthtech companies by May 2026, pairing studio building with permanent capital.
  • Northwell, Yale, and Aegis give portfolio companies immediate clinical sites and enterprise buyers.
  • Aegis targets AI-native healthcare workflows, biomarkers, consumer care, and real-world data.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Flexible Work Hours

Company Equity

Wellness Program

Mental Health Support

Company News

Yahoo Finance
Apr 14th, 2026
Yale-born fetal brain monitoring startup Wavelet secures $7M to prevent birth injuries

Wavelet Medical has secured $7 million in seed funding from Aegis Ventures to commercialise the first non-invasive, AI-powered fetal electroencephalography monitoring platform. The technology, developed at Yale, aims to detect fetal brain distress in real time and prevent avoidable brain injury at birth. Founded by Liz Golden, Dr Emily Lee and Dr Jose Cortes-Briones, Wavelet uses EEG captured through the mother's abdomen and reconstructed with AI algorithms to identify neurological distress, addressing limitations of traditional fetal heart rate monitoring, which is indeterminate in up to 85% of births. The platform targets a significant problem: over 35,000 infants suffer birth-related brain injuries annually in the US alone. Wavelet's partnership with Aegis Ventures will accelerate product development, clinical adoption and commercialisation of the technology.

PR Newswire
Apr 14th, 2026
Aegis Ventures and Wavelet Medical Aim to Redefine the Standard of Care in Fetal Medicine

/PRNewswire/ -- A breakthrough in fetal brain monitoring developed at Yale is moving from laboratory discovery to global commercialization through a pivotal...

Teknovation.biz
Nov 25th, 2024
News & Notes | Foundersforge Joins Village Capital’S Resource Iii Program For Entrepreneur Support Organizations

From Knoxville: The Knoxville Technology Council is asking local business representatives to complete its latest KTech Pulse 2024 Survey. Noting that the organization wants to get the pulse of Knoxville-area... The post News Notes | FoundersForge joins Village Capitals Resource III Program for Entrepreneur Support Organizations appeared first on Teknovation.biz.

Aegis Ventures
Oct 10th, 2023
Our Focus

We are driven by the mission to build companies that solve society's greatest problems, informed by the belief that the nexus of profits and purpose will create a virtuous cycle of impact that moves the world forward.

PR Newswire
Aug 22nd, 2023
Ascertain Announces Leadership Team With Appointment Of Ceo Mark Michalski, M.D. And Executive Chairman Gregg Fergus

Michalski, an Amazon alum, and Fergus, ex-CEO of 4Catalyzer, will lead the company creation platform building AI applications in healthcare.NEW YORK, Aug. 22, 2023 /PRNewswire/ -- Ascertain, a healthcare AI company creation platform, today announced the formation of its leadership team with the appointment of CEO Mark Michalski, M.D. and Executive Chairman, Gregg Fergus. Michalski and Fergus will lead Ascertain in its mission to merge deep technical, operational, and clinical expertise to deliver high-quality, equitable, and affordable healthcare.Michalski brings two decades of executive leadership experience to Ascertain. Prior to Ascertain, Michalski led strategic development for healthcare and life sciences at Amazon, was Founding Executive Director at Mass General Brigham/Harvard's Center for Clinical Data Science, and served as President and CMO of two publicly traded companies - Butterfly Network and Hyperfine Research. He is a board-certified radiologist and completed his medical training at Yale and Stanford.Fergus and Michalski met and collaborated closely at the venture studio 4Catalyzer where Fergus was CEO, launching several leading healthcare companies including Butterfly Network, Hyperfine Research, AI Therapeutics, and Quantum Si